ALT vs XLK
Altimmune Inc (ALT) versus Technology Select Sector SPDR® Fund (XLK) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Technology Select Sector SPDR® Fund (XLK) common stock listed on US.
Latest reported ALT revenue for 2025-09-30 was $5.0K. Net income was -$60.7M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. ALT currently screens at market cap $527.0M.
XLK does not have a complete income-statement cache yet.
ALT currently screens at market cap $527.0M. XLK currently screens at market cap $0.
Not investment advice. Open the ALT and XLK stock pages for the full models.
Not investment advice.